🇺🇸 FDA
Patent

US 8563691

Lysosomal targeting peptides and uses thereof

granted A61KA61K38/47A61P

Quick answer

US patent 8563691 (Lysosomal targeting peptides and uses thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/47, A61P, A61P3/00, A61P43/00